On February 17, 2022, the Vietnamese Ministry of Health issued Decision No. 69/QD-QLD granting conditional circulation registration certificates for three drugs containing the active substance Molnupiravir produced domestically to treat COVID-19. The Drug Administration of Viet Nam recommends that people should pay attention to the below-mentioned recommendations to ensure safety and effectiveness during the use of Molnupiravir.

Designing by QUANG THAO - Translating by T.VY